share_log

Vaxart Completes Enrollment Of The Sentinel Cohort In Its Phase 2b Study Of Its COVID-19 Oral Pill Vaccine Candidate

Benzinga ·  Dec 3 05:02
Vaxart Completes Enrollment Of The Sentinel Cohort In Its Phase 2b Study Of Its COVID-19 Oral Pill Vaccine Candidate
Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more
    Write a comment